Vaccine to be developed by U.S.-based Chiron seeks to tame bird flu

WASHINGTON (AP) - The National Institutes of Health awarded Chiron Corporation a $1.194-million contract to develop up to 40,000 doses of vaccine against H9N2 avian influenza, a type of bird flu that is less lethal but more widespread than the strain that killed 27 this year in Asia. ...More